INTRODUCTION
During human fetal development the adrenals are large and grow rapidly. At birth they are proportion¬ ately 20 times the size of the adult adrenals, but soon after birth they shrink rapidly (Pepe & Albrecht, 1990) . This involution has long been known to be due to the rapid degeneration and disappearance of the fetal zone, which comprises 80% of the fetal gland (Lanman, 1953) . Regulation of human fetal adrenal (HFA) growth and maturation is thought to involve the concerted actions of pituitary adrenocorti¬ cotrophin (ACTH) and placental and fetal growth factors, which are at least partly produced locally in the adrenals, where they act via paracrine or autocrine mechanisms (Pepe & Albrecht, 1990; Feige & Baird, 1991) .
Normal fetal adrenal development depends on nor¬ mal pituitary ACTH secretion, for in anencephalic fetuses serum ACTH levels are low (Allen et al 191A; Winters et al 191A) and the fetal zone of the adrenals is hypoplastic (Benirschke, 1956 ). Until about 16 weeks of gestation, however, adrenal growth appears to be independent of ACTH, for even in anencephalic fetuses the adrenals develop normally up to this age (Gray & Abramovich, 1980) . During the last few years increasing evidence has suggested that regula¬ tion of adrenal growth and function involves auto/ paracrine polypeptide growth factors, which are produced in many fetal tissues and in the placenta. These include at least insulin-like growth factors (IGFs)-I and -II, insulin, basic fibroblast growth factor (bFGF), transforming growth factor-ß 1 (TGF-ßl), and epidermal growth factor (EGF), and perhaps also other, as yet unidentified, substances (Feige & Baird, 1991) .
The IGFs, especially IGF-II, are thought to be among the most important growth factors in the fetus during early as well as later fetal development both in man and other species (D'Ercole, 1987; Rechler & Nissley, 1990) . IGF-II may be especially important in fetal adrenal development, as HFAs are one of the richest sources of IGF-II mRNA in the human fetus (Han et al 1987 (Han et al , 1988 Voutilainen & Miller, 1988; Brice et al. 1989 ). Very strong IGF immunoreactivity, assumed to be predominantly IGF-II, has also been detected in HFAs (Han et al 19876) , suggesting that the high IGF-II mRNA levels are translated into pro¬ tein. In cultured HFA cells, ACTH increases IGF-II mRNA accumulation (Voutilainen & Miller, 1987 (Voutilainen & Miller, 1987) , suggesting that this upregulation may be a general mechanism for controlling the growth of steroid-producing organs.
To (Munsick, 1984) , varied from 14 to 20 weeks. Primary cell cultures were prepared as described previously Cytoplasmic RNA was extracted from cell cultures and analysed by Northern and dot blotting as described previously (Voutilainen et al 1986) . Human IGF-II cDNA (Bell et al 1984) , human -actin cDNA (Gunning et al 1983) and mouse ribosomal 28S cDNA (Arnheim, 1979) (Fig. 1) . This inhibitory effect of TPA was shown to be dose-dependent, the half-maximal inhibitory dose being between 1 and 10 pg/1 (Fig. 3) TPA did not affect cell viability as studied with phasecontrast microscopy, but it inhibited the ACTHinduced contraction response . The inactive phorbol ester 4aPDD (100 pg/1) was without effect, indicating that the effect of TPA was specific (not shown). (Bu)2cAMP, like ACTH, is known to increase IGF-II mRNA in fetal adrenal cells (Voutilainen & Miller, 1987 (Fig. 4) . TPA attenuated the ACTH-, (Bu)2cAMP-, CT-and FK- induced IGF-II mRNA accumulation to the same (Tamaoki et al 1986) . This led to a seven-to ninefold increase in IGF-II mRNA levels in repeated experiments, staurosporine being a more potent stimulator than ACTH (Fig. 5) . The stimula¬ tory effect of staurosporine was also shown to be figure 5. Effect of staurosporine on IGF-II mRNA levels in cultured human fetal adrenal cells. The cells were first cultured to subconffuency and then stimulated with the agents indicated for 2 days before RNA extraction. Control, no stimuli (C), ACTH (200 pg/1; A), staurosporine (100 nmol/1; S), TPA (10 pg/1; T). IGF-II mRNA was analysed as in Fig. 2 . Each column represents densitometric scanning data from duplicate cell cultures (mean ± range), with the control adjusted to 100%. dose-dependent (2-8-fold increase at 10 mmol/1, 6-9-fold increase at 100 mmol staurosporine/1 ; data not shown). When ACTH and staurosporine were added to the cell cultures at the same time, the IGF-II mRNA levels were slightly higher than in cells treated with ACTH alone. Staurosporine was able to block the inhibitory effect of TPA on IGF-II mRNA levels (Fig. 5) . This suggests that the effects of TPA in HFA cells are due to PKC activation.
We next evaluated the effects of various polypeptide growth factors on IGF-II mRNA levels in HFA cells, as these substances are known to be involved in the regulation of adrenocortical growth and function in both man and other species (Feige & Baird, 1991) . IGF-I (100 pg/1), IGF-II (100 pg/1) and GH (1 mg/1) all increased basal IGF-II mRNA accumulation slightly, and they further increased the ACTHinduced IGF-II mRNA levels as shown in Fig. 6 . Statistical analysis of the pooled paired data (Wilcoxon's test) from three different experiments showed that these stimulatory effects were also statis¬ tically significant (P< 0-005) for all the comparisons, except for control vs IGF-I (P = 005). This finding suggests that a positive auto/paracrine regulatory sys¬ tem may act at the adrenal level, local IGF production further enhancing its own synthesis. It also raises the possibility that GH may stimulate adrenal growth via increased IGF-II production. TGF-ßl was found to inhibit both ACTH-induced and basal IGF-II mRNA levels (Fig. 7) . This accords with the previous observa¬ tion that TGF-ßl inhibits the growth of HFA cells (Riopel et al 1989a) . However, the inhibitory effect was seen only in serum-free conditions, and inhibi¬ tions of ACTH-induced IGF-II mRNA accumulation required preincubation for 12 h with TGF-ßl before addition of ACTH. We also investigated the effects of EGF (100pg/l) and bFGF (100pg/l) on IGF-II gene expression. However, neither EGF nor FGF affected the IGF-II mRNA levels in HFA cells (results not shown).
DISCUSSION
The key role of ACTH in fetal adrenal growth is well established in vivo (Pepe & Albrecht, 1990 ). Shortterm exposure to ACTH in cell culture conditions inhibits adrenal cell proliferation and thymidine incorporation in both man (Simonian & Gill, 1981) and the other species (Hornsby & Gill, 1977; Salmenperä & Kahri, 1977) . However, in long-term cultures, HFA cells were found to proliferate even in the presence of ACTH (Kahri et al 1976; DiBlasio et al. 1990) , and ACTH stimulated HFA cell growth as measured by determining total protein (Roos, 1974) . There is increasing evidence that, in addition to figure 6. Effects of IGF-I, IGF-II and GH on IGF-II mRNA levels in cultured human fetal adrenal cells. The cells were first cultured for 7 days in serum-containing medium (10% fetal calf serum), and then moved into serum-free medium. The cultures were treated for 2 days in serum-free medium with ACTH (200 pg/1; A), IGF-I (100 pg/1), IGF-II (100 pg/1) and GH (1 mg/1) as indicated. IGF-II mRNA was analysed as in Fig. 2 (Pepe & Albrecht, 1990; Feige & Baird, 1991) . The most important of these growth factors are IGF-II, bFGF, EGF and TGF-ßl, but there may also be other adrenal regulatory factors produced at least by the placenta and the pituitary (Samsondaar & Kudlow, 1987; Simonian et al 1987; Riopel et al. 1989e ).
ACTH has earlier been suggested to mediate its growth-promoting effects on HFA cells via local IGF-II production (Voutilainen & Miller, 1987) . The present study confirms and extends this previous find¬ ing, and also shows that IGF-II peptide is released in the conditioned medium. This is an important obser¬ vation, for IGF-II mRNAs are not always translated efficiently (Haselbacher et al. 1987 (Rainey et al 1988) , and PKC-dependent mechanisms have been suggested to be involved in the regulation of HFA steroidogenesis McAllister & Hornsby, 19876, 1988 ). The present study shows that TPA, a widely used activator of PKC (Castagna et al. 1982) (Daughaday & Rotwein, 1989) . Our finding is in accord with reports that in certain conditions GH is able to stimulate IGF-II mRNA levels (Turner et al 1988) and secre¬ tion (Ramasharma & Li, 1987 (Simonian & Gill, 1981; Crickard et al 1981) . bFGF is also produced locally in HFA cells, its production being up-regulated by ACTH to the same degree as IGF-II production (Mestano et al. 1991) . FGF receptors are also expressed in HFA cells (Korhonen et al. 1991) , and in bovine adrenals they are up-regulated by ACTH (Savona & Feige, 1991) . TGF-ßl is a growth inhibitor for HFA cells (Riopel et al 1989 ) , and is also produced in bovine adrenals (Williams & Allen- 
